Category: Debates & Comparisons
Chamomile is not even registered by European regulators as a sleep aid, and lemon balm's most quoted trial had no placebo group. Here is what each calming herb has actually been shown to do, and which one fits which kind of stress.
Category: Debates and Comparisons | Reading time: ~12 min | Level: Intermediate
Two mugs of tea, both marketed as the antidote to a racing mind before bed. One smells of apples and hay, the other of citrus and mint. Ask ten wellness sites which is better and you will get ten confident, mostly interchangeable answers, several of them lifted from the same handful of source articles. The honest answer is less tidy and considerably more useful: chamomile and lemon balm are not really competing for the same job, and the regulator that actually reviewed the human trial evidence on both did not even agree that chamomile belongs in a sleep conversation at all.
That last point is worth sitting with, because it upends the usual assumption. Most people treat chamomile as, almost by definition, the sleep herb. Europe's own herbal medicines committee, having reviewed the evidence in detail, registered chamomile for five traditional uses: mild digestive upset, symptoms of the common cold, minor mouth and throat inflammation, skin irritation in sensitive areas, and minor skin inflammation such as sunburn. Sleep is not on that list. Anxiety is not on that list. That does not mean chamomile does nothing for a wired mind at bedtime, the newer trial evidence suggests a modest effect, but it does mean the herb's reputation has run well ahead of what regulators were willing to put their name to.
Lemon balm sits in a different, though equally imperfect, spot. Traditionally used and thinly trialled like chamomile, its own regulatory dossier does at least name mild mental stress and sleep as accepted traditional uses. So this is not chamomile versus lemon balm in the sense of a contest with one winner. It is two mild, traditionally used herbs with genuinely different evidence shapes, aimed at overlapping but not identical problems. Here is what each has actually been shown to do, and where the marketing gets ahead of the data.
Chamomile usually means German chamomile, botanically Matricaria chamomilla, though the older name Matricaria recutita still appears on most product labels and on the European regulatory monograph itself. The dried flower head is the part used, most often steeped as a tea, and its calming reputation is generally credited to the flavonoid apigenin, alongside a mix of volatile oils and other flavonoids [3].
Lemon balm is Melissa officinalis, a lemon-scented member of the mint family with a long European history as a calming culinary and medicinal herb. Its most studied active compound is rosmarinic acid, alongside a group of triterpenoids, thought to work partly by slowing the breakdown of GABA, the brain's main calming neurotransmitter, which would in theory raise GABA levels in the brain [10].
Both plants are used in much the same casual way, as a tea or a standardised extract taken by mouth, and both are pitched at a similar problem: a mind that will not settle. Where they differ is in exactly what each has actually been shown, and not shown, to do about it.
Start with Europe's regulator, because it resets expectations quickly. The EU herbal monograph on chamomile flower lists five approved indications, all under the lower traditional-use tier, and none of them is sleep or anxiety: minor gastrointestinal complaints such as bloating, symptoms of the common cold, minor mouth and throat inflammation, adjuvant care for skin and mucosal irritation in the anal and genital area, and minor skin inflammation including sunburn [3]. If chamomile's sleep reputation rested on regulatory approval, this comparison would have nothing to compare.
The clinical trial literature tells a more interesting, if still modest, story. A 2019 meta-analysis pooling 12 randomised trials found no effect on state anxiety across three trials (a standardised mean difference of minus 0.15, comfortably straddling zero) and no significant change on the single available insomnia trial. But two other outcomes did move: a significant improvement on the Hamilton Anxiety scale in people with a diagnosis of generalised anxiety disorder, at both two and four weeks, and a significant improvement in self-reported sleep quality [1].
That sleep quality signal reappeared in a larger, more recent pooling: a 2024 meta-analysis of ten trials and 772 participants found a significant improvement on the Pittsburgh Sleep Quality Index [2]. Read the fine print and confidence drops fast. The statistical heterogeneity across the pooled studies reached 88.4%, an extremely high figure meaning the trials were not really measuring a consistent effect. Sleep efficiency did not improve, and worsened in one study. Daytime functioning, arguably the thing that matters most to a tired person, did not change in any of the three studies that measured it [2]. Subjective sleep quality moving while the more objective measures stay flat looks like the fingerprint of a calming bedtime ritual more than a pharmacological sedative.
The anxiety picture is genuinely mixed rather than simply negative. A 2022 international treatment guideline from the WFSBP and CANMAT graded chamomile "not currently recommended" for generalised anxiety disorder, in explicit contrast to lavender, which the same guideline rated positively [4]. A separate Bayesian network meta-analysis of 29 trials across 12 herbs found chamomile's anxiety effect essentially indistinguishable from placebo, though the authors were careful to say this proved neither effectiveness nor ineffectiveness given how wide the statistical uncertainty was [5]. NCCIH's own summary calls the anxiety evidence preliminary and notes that the one available insomnia review found no benefit [6].
Honest grade: limited to moderate for subjective sleep quality specifically, and limited and conflicting for anxiety. Chamomile is a real, traditionally used, well tolerated calming herb whose best evidence is thinner and shakier than its reputation suggests, and whose own regulator does not recognise it as a sleep or anxiety remedy at all.
On safety, chamomile is genuinely clean in the way that matters most: the NIH's LiverTox database rates it an unlikely cause of liver injury despite widescale use [7]. Its two real safety concerns are narrower than people expect. First, allergy: chamomile belongs to the daisy family, and people sensitised to ragweed, mugwort or related plants can react, occasionally severely. A study of 14 sensitised patients found ten had immediate, in some cases life-threatening, reactions [9]. Second, a single but striking case report describes an elderly woman on warfarin admitted with multiple internal bleeds after using chamomile tea and lotion together, attributed to chamomile's coumarin content. It is one case, not a pattern, but NCCIH lists warfarin among the substances flagged for possible interaction with chamomile [6][8].
Lemon balm's regulatory position is narrower in scope but more directly relevant to this comparison. The EU monograph registers Melissa officinalis leaf, on a traditional-use basis only, for two things: relief of mild symptoms of mental stress and to aid sleep, and mild gastrointestinal complaints including bloating and flatulence [10]. Unlike valerian, lemon balm has never been granted Europe's higher well established use tier, so this traditional registration rests on long-standing use rather than a modern trial base clearing a higher bar [10].
The human trials are a genuinely mixed bag in design quality, smaller in number than chamomile's, and worth walking through honestly rather than cherry-picked. The earliest and most cited work comes from a pair of crossover trials in healthy young adults, not people with a diagnosed anxiety or sleep condition. A 2002 trial found that a 300mg and a 900mg single dose each increased self-rated calmness versus placebo, without a clean dose-response relationship [11]. A follow-up 2003 trial in 20 volunteers tested single doses of 600, 1000 and 1600mg and found the highest dose produced the clearest combination of improved memory performance and increased calmness, while the lower doses showed some slowing on timed tasks [12]. These are acute, single-dose studies in well people, useful for showing lemon balm has a measurable central effect, not a demonstration that it treats anxiety or insomnia.
The trial most often quoted as lemon balm's anxiety and sleep evidence is a 2011 pilot study, and it needs an honest caveat that tends to disappear from marketing copy: it was open-label, with no placebo group and no blinding [13]. Twenty stressed volunteers took 600mg of a standardised extract daily for 15 days and reported an 18% reduction in anxiety, a 15% reduction in associated symptoms, and a 42% reduction in insomnia, with 95% of participants responding to some degree [13]. Those are striking numbers, and they are also exactly the kind of numbers an open-label trial without a placebo arm tends to produce, since participants who know they are taking an active treatment, and are asked how they feel every few days, reliably report improvement regardless of the capsule's contents.
The more convincing modern evidence is a 2023 randomised, double-blind, placebo-controlled trial in 100 healthy adults with moderate stress, anxiety or poor sleep, run over three weeks using a phospholipid-carrier branded extract designed to improve absorption [14]. It found significant improvements versus placebo on standard depression, anxiety and stress scales, and on the Pittsburgh Sleep Quality Index [14]. This is a properly controlled trial and the single best piece of evidence lemon balm currently has, but it tested one specific, bioavailability-enhanced proprietary extract rather than the loose tea or generic capsule most people actually buy, so the result does not automatically transfer to every lemon balm product on a shelf.
Put together, no meta-analysis or systematic review of lemon balm's clinical trials for anxiety or sleep currently exists at the depth chamomile's evidence has been pooled, and that gap is itself informative. The trial base is smaller, more heterogeneous in preparation and dose, and weighted toward acute, healthy-volunteer designs. Honest grade: limited, traditional use only, with one encouraging modern RCT and an oft-cited pilot result that is weaker than it is usually presented as being.
Safety is generally reassuring, with two specific points worth flagging rather than glossing over. Lemon balm's own EU monograph states plainly that it may impair the ability to drive or operate machinery, the same caution given to genuinely sedating substances [10]. And laboratory and animal research has found that lemon balm extract can bind to and inhibit thyroid stimulating hormone; the monograph itself notes the clinical relevance of this finding is not known, and no confirmed human case has established the interaction, but it is documented in the pharmacological literature and worth a conversation with a prescriber rather than an assumption either way [10]. Pregnancy and lactation safety has not been established, so the monograph advises against use in those circumstances [10].
| Feature | Chamomile | Lemon Balm | |---|---|---| | Plant part | Flower head | Leaf | | Proposed mechanism | Apigenin, mild proposed action on GABA-A receptors | Rosmarinic acid, proposed inhibition of GABA breakdown | | European regulatory status | Traditional use only; registered for digestion, colds, mouth and skin, not sleep or anxiety [3] | Traditional use only; registered for mild mental stress and sleep, and mild GI complaints [10] | | Best evidence | Subjective sleep quality, significant in two meta-analyses, very high heterogeneity [1][2] | 2023 placebo-controlled RCT (n=100) on a proprietary extract, significant on stress, anxiety and sleep scales [14] | | Weakest evidence | Anxiety: mixed to null across independent syntheses [4][5] | 2011 pilot, frequently cited, but open-label with no placebo group [13] | | Evidence grade | Limited to moderate, sleep quality specifically | Limited, traditional use, one strong modern RCT | | Typical use pattern | Evening wind-down tea | Daytime nervous tension, or evening extract for sleep | | Key safety flag | Asteraceae allergy; rare warfarin case report [8][9] | May impair driving; theoretical, unconfirmed thyroid hormone interaction [10] |
Side by side, the two herbs share more than the shelf they sit on: both are traditional-use-only in Europe, both are proposed to act on GABA by different routes, and both have their best data on a subjective, rather than objective, outcome. The real differences are in timing and specificity. Chamomile's traditional claim points toward digestion and skin, with its sleep data arriving almost as a side finding from modern trials. Lemon balm's traditional claim points directly at mental stress and sleep, but with a thinner, more mixed trial base behind it.
Name your problem first, because it does most of the deciding. If the issue is a daytime, wired, ruminating kind of tension, chamomile's registered traditional uses do not even cover it, while lemon balm's acute trials were literally measuring calmness and mood within an hour of a dose, making it the more directly relevant herb for that pattern [11][12]. If the problem is a racing mind specifically at bedtime, chamomile's clearest and most repeated signal sits exactly there, on subjective sleep quality, even though the effect is modest and unconfirmed on objective measures [1][2].
Second, if digestion and nerves misbehave together, a knotted stomach alongside a wired mind, both herbs actually have a firmer traditional claim on the gut than on the brain: chamomile for minor digestive complaints and mouth or throat irritation, lemon balm for bloating and flatulence [3][10]. That is arguably each herb's most solid regulatory ground, and it is worth remembering when the marketing leans entirely on sleep or calm.
Third, form and timing matter more than people assume. Chamomile is almost always taken as tea, which builds the wind-down ritual into the product itself. Lemon balm shows up as tea, capsules and standardised extracts, and its best trial evidence used a specific delivery form rather than a garden-variety tea bag, so a standardised extract is a closer match to that evidence than steeped leaves [14].
Fourth, know the honest limits. Neither herb has been shown, in a rigorous placebo-controlled trial, to resolve diagnosed insomnia or generalised anxiety disorder. If sleep is poor most nights for weeks, or anxiety is limiting daily function, that calls for a conversation with a GP, not a supplement aisle decision.
If you want an evening ritual, a warm cue that the day is over, and you are comfortable with modest, subjective, sleep-quality-only evidence, chamomile is the better fit for bedtime, and it doubles as the more established choice if your stomach is unsettled too [1][2][3].
If your problem shows up earlier in the day, a knot of nervous tension at a desk, before a stressful event, or alongside an evening meal rather than only at lights-out, lemon balm is the more directly relevant herb. Its acute trials measured daytime calmness specifically, and it holds the single best-controlled trial either herb has [11][12][14].
If you cannot decide because your problem is both, that is not indecision, it is an accurate read of your situation. Many traditional blends and modern calming products combine lemon balm and chamomile precisely because the two overlap without duplicating each other, one leaning toward daytime nervous tension, the other toward the evening wind-down. Pairing two mild, traditionally used herbs is a reasonable, low-risk experiment. Expecting either one alone to outperform its actual evidence is not.
Both herbs are well tolerated by most healthy adults at food and tea-level doses, but each carries specific cautions worth knowing rather than assuming away.
Chamomile: avoid it if you have a known allergy to Asteraceae family plants such as ragweed, daisies, chrysanthemums or mugwort, since reactions can be severe [9]. There is a single documented case of serious bleeding in a warfarin patient who combined chamomile tea and topical lotion, and NCCIH lists warfarin among substances that may interact with chamomile [6][8]. Chamomile's oral tea infusion has an established pregnancy and lactation safety record per the EU monograph, though extract and tincture forms do not, and are not recommended [3].
Lemon balm: its own monograph states it may impair the ability to drive or operate machinery, a caution worth taking seriously even though the herb is not typically thought of as sedating [10]. Preclinical research has found lemon balm extract can inhibit thyroid stimulating hormone; the clinical relevance in humans is not established, but anyone on thyroid hormone replacement should raise it with a prescriber rather than guess. Pregnancy and lactation safety has not been established, and the monograph advises against use in those circumstances [10].
For either herb, stacking with sedatives, sleep medication or alcohol is not advised without medical guidance, since layering calming agents can add up in ways a single mild herb would not.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
Our approach here is the one we take everywhere: name the evidence grade before naming a product. Both of these herbs earn a place on a shelf; neither earns a bigger claim than its data supports.
If your pattern is a racing mind at bedtime, our chamomile sleep tea is built for exactly that ritual, a warm drink at a consistent hour, described the way the evidence actually reads: a mild, traditionally used calming aid whose clearest signal is on how rested you feel, not on the more objective measures of sleep itself. We would rather you knew that going in than discover it after buying on a bigger promise than the trials support.
For the daytime nervous tension that lemon balm's trials speak to more directly, or for the shared GABA mechanism behind both herbs, the wider Remedy Library and our companion glossary pages go deeper without inflating the claim. That is the whole service: honest grading, matched to your actual problem, rather than a confident pitch for whichever herb happens to be in stock this week.
1. Hieu TH, et al. (2019). Chamomile for anxiety, insomnia and generalised anxiety disorder: a systematic review and meta-analysis of 12 randomised controlled trials. Phytotherapy Research. PMID 31006899. No effect on state anxiety; significant improvement on GAD symptoms and subjective sleep quality. 2. Kazemi F, et al. (2024). Chamomile and sleep quality: a systematic review and meta-analysis of 10 trials, n=772. Complementary Therapies in Medicine. PMID 39106912. Significant PSQI improvement but 88.4% heterogeneity; sleep efficiency and daytime functioning unchanged. 3. European Medicines Agency, Committee on Herbal Medicinal Products (2015). European Union herbal monograph on Matricaria recutita L., flos (EMA/HMPC/55843/2011). Five traditional-use indications for digestion, colds, mouth, skin; no sleep or anxiety indication. 4. Sarris J, et al., World Federation of Societies of Biological Psychiatry and Canadian Network for Mood and Anxiety Treatments (2022). International clinical treatment guideline grading chamomile "not currently recommended" for generalised anxiety disorder. PMID 35311615. 5. Zhang J, et al. (2022). Bayesian network meta-analysis of 29 trials across 12 herbs. Pharmacological Research. PMID 35378276. Chamomile's anxiety effect versus placebo not distinguishable from zero; evidence insufficient to confirm or rule out efficacy. 6. National Center for Complementary and Integrative Health (2023). Chamomile. Government evidence synthesis; anxiety evidence described as preliminary, no insomnia benefit found in the one available review, warfarin interaction flagged. 7. National Institutes of Health, LiverTox (2020). Chamomile, likelihood score E. Government evidence database entry; unlikely cause of clinically apparent liver injury despite widescale use. NBK548163. 8. Segal R, Pilote L (2006). Warfarin interaction with Matricaria chamomilla. Canadian Medical Association Journal. PMID 16636327. Single case report of internal bleeding attributed to combined chamomile tea and lotion use. 9. Reider N, et al. (2000). Anaphylaxis to camomile: clinical features and allergen cross-reactivity. Clinical and Experimental Allergy. PMID 10998021. 14 sensitised patients, 10 with immediate, some life-threatening, reactions. 10. European Medicines Agency, Committee on Herbal Medicinal Products (2013). Community herbal monograph on Melissa officinalis L., folium (EMA/HMPC/196745/2012). Traditional-use registration for mild mental stress, sleep and GI complaints; driving caution; preclinical thyroid stimulating hormone note; pregnancy not recommended. 11. Kennedy DO, et al. (2002). Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) to healthy young volunteers. Pharmacology, Biochemistry and Behavior. PMID 12062586. Single-dose crossover trial; increased calmness at 300mg and 900mg versus placebo. 12. Kennedy DO, et al. (2003). Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. PMID 12888775. n=20 crossover trial; 1600mg dose produced the clearest calmness and memory benefit. 13. Cases J, et al. (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism. PMID 22207903. Open-label, no placebo group, n=20, 15 days; self-reported reductions in anxiety and insomnia. 14. Bano A, et al. (2023). The possible calming effect of subchronic supplementation of a standardised phospholipid carrier-based Melissa officinalis L. extract in healthy adults with emotional distress and poor sleep conditions. Frontiers in Pharmacology. PMID 37927585. Randomised, double-blind, placebo-controlled trial, n=100, 3 weeks; significant improvement on DASS and PSQI scales versus placebo.
Chamomile has the more repeated signal specifically on sleep, with two independent meta-analyses finding a statistically significant improvement in self-reported sleep quality, though the pooled evidence carries very high heterogeneity and objective sleep measures barely move. Lemon balm's sleep evidence is thinner and rests more heavily on one modern placebo-controlled trial of a specific proprietary extract, plus an open-label pilot that lacked a placebo group. If bedtime wind-down is the whole problem, chamomile has the deeper, if still modest, track record.
Chamomile is a daisy-family flower used mainly as tea, with active compounds including the flavonoid apigenin, and its European registration covers digestion, colds, mouth and skin, not sleep or anxiety. Lemon balm is a mint-family leaf whose main active compound, rosmarinic acid, is thought to raise GABA levels in the brain, and its own European registration does name mild mental stress and sleep as traditional uses. In practice, chamomile leans toward an evening ritual and gut calm, lemon balm toward daytime nervous tension, though both overlap.
The honest answer is possibly, modestly, and mostly on how rested you report feeling rather than on how quickly or deeply you actually sleep. Two meta-analyses found a statistically significant improvement in subjective sleep quality, but one had 88% heterogeneity across trials and neither found a change in sleep efficiency or daytime functioning. That pattern, subjective quality moving while objective sleep does not, looks more like a calming ritual effect than a sedative one.
There is a real, if limited, signal. Small acute trials in healthy volunteers show increased self-rated calmness within an hour of a single dose, and a 2023 placebo-controlled trial of a specific extract found significant improvement on standard anxiety and stress scales over three weeks. The most famous supporting trial, from 2011, had no placebo group, so its striking 18% anxiety reduction figure should be read as encouraging rather than proven.
Yes, and many traditional blends and modern sleep products do exactly this, on the reasoning that the two herbs cover slightly different ground rather than duplicating each other. There is no strong evidence the combination outperforms either herb alone, but both have good general safety records at food and tea-level doses. As with any combination, avoid stacking on top of sedatives or alcohol without checking first.
No, and this surprises most people. The EU herbal monograph on chamomile flower registers five traditional uses: minor digestive complaints, cold symptoms, mouth and throat irritation, skin and mucosal irritation in the anal and genital area, and minor skin inflammation including sunburn. Sleep and anxiety are absent from that list entirely, despite chamomile's popular reputation as the bedtime herb.
Both have good general safety records at ordinary tea or supplement doses in healthy adults. Chamomile's main risks are allergy in people sensitised to ragweed or related daisy-family plants, and a rare case-reported interaction with warfarin. Lemon balm's own monograph warns it may impair driving, and animal research has flagged a theoretical, unconfirmed interaction with thyroid hormone. Neither has strong long-term human safety data beyond typical traditional use.
Lemon balm has the more directly relevant evidence here. Its acute clinical trials specifically measured mood and calmness during the day in alert volunteers, not just at bedtime, while chamomile's registered traditional uses do not mention stress or calm at all outside of gut symptoms. If the problem shows up at a desk rather than in bed, lemon balm is the more logical herb to trial first.
Chamomile fits that specific job better. Its clearest and most repeated evidence is on subjective sleep quality with evening use, and the ritual of a warm tea at a consistent hour is arguably doing real work alongside whatever the herb itself contributes. Treat it as a modest aid within a genuine wind-down routine, not a substitute for one, and judge it over one to two weeks of consistent use rather than a single night.
Lemon balm is the more relevant herb for that pattern. Its acute trials measured mood and calmness in alert people during waking hours, and a 2023 controlled trial found improvement on stress and anxiety scales over three weeks of daily use, not just at night. Chamomile's registered traditional uses do not cover daytime stress at all. Start with a modest, standardised dose and give it at least a couple of weeks before judging it.
Lemon balm carries a documented, though unconfirmed in humans, theoretical caution here. Laboratory and animal research has found lemon balm extract can bind to and inhibit thyroid stimulating hormone, and the herb's own European monograph notes this finding without knowing its clinical significance. Chamomile has no comparable flag in its safety literature. Either way, raise any calming herb with the clinician managing your thyroid medication rather than guessing.
Be cautious with both, and treat chamomile tea as the narrower exception. Chamomile's own European monograph states that safety during pregnancy has been established specifically for the herbal tea infusion, though not for extracts or tinctures. Lemon balm's monograph states plainly that safety in pregnancy has not been established and recommends against use. This is exactly the kind of decision to make with a midwife or GP, not from an article.